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 Abstract  
Background: An important concern revealed in the public discussion of the use of genetically 
modified (GM) plants for human consumption, is the potential transfer of DNA from these plants to 
bacteria present in the gastrointestinal tract. Especially, there is a concern that antibiotic resistance 
genes used for the construction of GM plants end up in pathogenic bacteria, eventually leading to 
untreatable disease. 
 
Findings: Three different bacterial species (Escherichia coli, Bacillus subtilis, Streptococcus 
gordonii), all natural inhabitants of the food and intestinal tract environment were used as recipients 
for uptake of DNA. As source of DNA both plasmid and genomic DNA from GM plants were used 
in in vitro and in vivo transformation studies. Mono-associated rats, creating a worst-case scenario, 
did not give rise to any detectable transfer of DNA.  
 
Conclusion: Although we were unable to detect any transformation events in our experiment, it 
cannot be ruled out that this could happen in the GI tract. However, since several steps are required 
before expression of plant-derived DNA in intestinal bacteria, we believe this is unlikely, and 
antibiotic resistance development in this environment is more in danger by the massive use of 
antibiotics than the consumption of GM food harbouring antibiotic resistance genes.  
 
 
 Findings  
A major concern in relation to marketing of genetically modified (GM) plants for human 
consumption is the possible transfer of antibiotic resistance genes used as marker genes in GM 
plants to the human or animal intestinal microbiota. The uptake of these resistance genes by bacteria 
present in the gastrointestinal (GI) tract could potentially render pathogens resistant to antimicrobial 
agents currently used, thereby resulting in untreatable diseases [1]. 
Transformation is the only known gene transfer mechanism by which bacteria can take up DNA 
released from plants. One key factor is thus DNA persistence in the GI tract, the availability of 
competent bacteria, and their state of competence [2]. Several studies indicate that DNA, and 
especially plant-associated DNA, is able to survive the conditions in the GI tract and be available 
for uptake by bacteria resident in the gastrointestinal tract  [3-8].  
Several of the bacteria found in the GI tract, either carried by the food or innate GI bacteria, have 
been found to be naturally transformable [9]. But the question is whether these bacteria also possess 
or develop competence in this environment. In this work we used as recipients the naturally 
transformable bacteria Bacillus subtilis which is often a contaminant of food, and Escherichia coli 
and Streptococcus gordonii that are part of the normal gut microbiota. We used mono-associated 
rats that can be considered as a worst-case model, and as a biological magnifier making it possible 
to study one bacterial species separately and often in high number. All animal experiments were 
carried out under the supervision of the Danish National Agency for Protection of Experimental 
Animals. 
 
Escherichia coli 
In vitro experiments were performed using an overnight culture of DB1317 (Table 1) mixed with 
plasmid pMR2 (100 µg/ml) in Luria-Bertani (LB) media and incubated at 37 °C. Sampling at 2 and 
4 hrs gave rise to transformants on LB media containing chloramphenicol (25 µg/ml) at a frequency 
of up to 10-7 transformants (TF) per recipient (data not shown). Plasmid extraction and restriction 
analysis confirmed that transformants harboured the plasmid pMR2 (data not shown). Cells 
incubated without addition of plasmid DNA (negative controls) did not give rise to any 
chloramphenicol resistant colonies. When adding faecal or intestinal samples from germfree rats to 
the LB medium to a final concentration of 10%, and performing the same experiment as described 
above, no transformants were detected (detection limit 2.3 x 10-9 TF/rec).  
Although ex vivo experiments with intestinal and faecal samples could not detect any uptake of 
DNA, the situation may be different in vivo where specific environmental factors may be present 
enhancing uptake of DNA by E. coli. Therefore an in vivo experiment with E. coli strain MS15978 
(DB1317 harbouring plasmid pMR1) was performed. Four germfree Sprague-Dawley rats (14-17 
weeks old) bred and housed as previously described [6] were dosed p.o. by gavage with 1 ml cell 
suspension (app. 109 cfu/ml) of E. coli strain MS15978 at day 1 of the experiment. One rat served 
as a control and was not fed with plasmid DNA, while the other three animals received 100 µg 
plasmid pMR2 each working day from day 8 to 17 of the experiment. Dosing the rats with plasmid 
pMR2 gave us the opportunity to look at uptake (chloramphenicol resistance, 25 µg/ml) as well as 
homologous recombination (kanamycin resistance, 500 µg/ml) by marker-rescue of the deleted 
nptII gene on pMR1 [10]. The strain colonized the animals to a concentration of up to 1011 cfu/g 
faeces (Figure 1). However, the plasmid pMR1 was not stably maintained in the strain MS15978 
during colonization of the animals. Therefore a selective pressure was put on the plasmid (1000 
µg/rat/day of ampicillin p.o. by gavage) at day 10 to 17 of the experiment. This restored the 
population of pMR1 containing cells (see Figure 1). At sacrifice at day 17, pMR1 containing E. coli 
cells were found throughout the intestinal tract at the following app. densities: duodenum: 103 cfu/g; 
ileum: 106 cfu/g; caecum and colon: 108 cfu/g. Transformants were detected neither in faecal or 
intestinal samples on Brain Heart Infusion (BHI) media containing either chloramphenicol (25 
µg/ml) or kanamycin (500 µg/ml) (detection limit 100 cfu/g).   
In this study we observed low-frequency spontaneous transformation of E. coli strain DB1317 
growing in LB media without addition of divalent cations or temperature shift, conditions pivotal 
for high frequency transformation. However, adding faecal or intestinal samples from germfree rats 
to the LB media let drop the number below the detection limit of 2.3 x 10-9 TF/rec. This could 
indicate that adding these samples either inhibited uptake of DNA, or that the DNA was degraded in 
the samples. A recent published paper (Nordgaard et al., 2007) observed the same inhibitory effect 
of intestinal content from germfree mice on the transformation process of Acinetobacter baylyi. 
Previous studies incubating plant DNA in GI samples ex vivo showed that the DNA was rapidly 
degraded in samples from the small intestine, whereas hardly any degradation was observed when 
incubating the DNA in samples from the lower part of the GI tract [6]. However, DNA persistence 
was studied using PCR, a sensitive method needing only scarce amounts of DNA for amplification. 
Studies incubating plasmid DNA in faecal samples from germfree rats showed that by simple gel 
electrophoresis, the plasmid could not be observed after 10 minutes of incubation, whereas by PCR 
a strong band could be detected even after 20 min of incubation (unpublished results). Since the 
transformation frequency in LB media is already low, the degradation of DNA in the samples is 
probably lowering the transformation frequency further, so that a possible transfer event is below 
detection limit. The same may be true for the in vivo studies where no uptake of DNA by E. coli 
could be observed, in concordance with an earlier study showing that although plasmid DNA was 
detected in the GI tract, the concentration was very low [6].  
  
Bacillus subtilis 
Using minimal salt (MS) medium, the plasmid pAW105, and following the in vitro transformation 
procedure of Spizizen [11] we got a transformation frequency of up to 10-6 TF/recipient (Figure 2). 
PCR with primers detecting pAW105 sequences confirmed that the obtained transformants 
harboured the plasmid (data not shown). As such the used system for in vitro studies can be 
regarded as an efficient transformation system. Supplementing the MS medium with 10% intestinal 
contents (stomach, ileum, caecum, or colon) from B. subtilis mono-associated rats resulted in 
transformants from all samples with a frequency of up to 1.1 x 10-7 TF/recipients (data not shown). 
This showed that this concentration of intestinal content allows transformation of B. subtilis to 
nearly the same extent as in pure MS medium. 
One animal experiment was performed with ten germfree rats mono-associated with B. subtilis 168 
and eight of those fed high amounts of plasmid pAW105. Figure 3 shows that in spite of daily doses 
of overnight cultures containing app. 109 B. subtilis cells, the bacteria only reached a concentration 
in faeces ranging from 103 to 105 cfu/g. During the experimental period of three weeks, the animals 
received about 100 µg of plasmid DNA each working day, but neither in faecal or intestinal samples 
transformants on LB + Cm (5 µg/ml) were detected (detection limit 10 cfu/g).  
An explanation of lack of transformants in the rats could be the low number of B. subtilis present in 
the GI tract with app. 103 cfu/g in ileum, 103 cfu/g in caecum and 105 cfu/g in colon. In vitro the 
highest transformation frequency observed was 10-6 TF/recipient. Therefore the likelihood of 
detection of a transformed B. subtilis within a faecal population of 103-105 cfu/g is unlikely.  
 
Streptococcus gordonii 
Previous published studies have shown that the used strain, LTH 5597, is capable of taking up 
plasmid DNA and genomic plant DNA under in vitro conditions [12].  
The strain LTH 5597given by p.o gavage to ten germ-free rats at day 1 and 4 colonized well (Figure 
4), but it was noticed that the amount of erythromycin resistant cells was declining during the first 
week, indicating that plasmid pMK110 was lost from the population. Therefore, from day 8 of the 
experiment all animals received 100 µg erythromycin each working day throughout the rest of the 
experiment. As can be seen from the figure this restored the population of cells containing plasmid 
pMK110. 
At day 7 to 10 of the experiment, eight animals received 1 mg DNA extracted from GM potato; this 
corresponds to approximately 109 nptII genes. Faecal samples were taken and plated onto selective 
media (BHI containing 1 mg/ml kanamycin), but no transformants were detected (detection limit 10 
cfu/g faeces). To select for potential transformants, samples were pooled, incubated in Brain Heart 
Infusion (BHI) media containing 1 mg/ml kanamycin at 37 °C overnight, and plated onto selective 
media containing kanamycin. But again no transformants were detected (detection limit 10 cfu/ml).  
At day 22 of the experiment, the test animals received an overnight culture of E. coli harbouring the 
plasmid pMR2, which contains a whole copy of nptII but without a promoter. The strain established 
well in the animals with app. 108 cfu/g faeces, but again no kanamycin resistant colonies of S. 
gordonii were detected (detection limit 10 cfu/g faeces). At sacrifice the total number of bacteria in 
the different sections of the intestine where as following: duodenum: 104 cfu/g; ileum: 106 cfu/g; 
caecum and colon: 108 cfu/g. And also here no transformants were detected (detection limit 10 cfu/g 
intestinal content).  This is in agreement with another study with germ free rats mono-associated 
with S. gordonii and fed large amounts of plasmid DNA that also failed to show transformation in 
vivo [12].  
 Concluding remarks 
In the present study, the three studied bacterial species were unable to take up free DNA in a 
germfree animal model. Using germfree mice, another study using Acinetobacter baylyi also failed 
to show in vivo transformation [13]. However, there are several more transformable bacterial 
species that are relevant for the intestinal situation [9], so we cannot rule out the possibility of 
transformation to happen in the GI tract. Nevertheless, many steps are required before a successful 
transfer of an antibiotic resistance gene from plant to bacteria has occurred. The DNA has to be 
released from the plant material, the DNA must survive the harsh gastrointestinal environment; 
competent bacteria must be present and take up the DNA, and finally has the gene to be integrated 
into the genome in a place where it can be expressed. Therefore the development of antibiotic 
resistant pathogenic bacteria is much more favoured by the use of antibiotics thereby putting a 
selective pressure on the intestinal environment, than by the consumption of antibiotic resistance 
genes present in GM plants. 
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Legends to figures 
 
Figure 1 
Colonization of four mono-associated rats with E. coli strain MS15978. Faecal samples were plated 
on both BHI (♦) and BHI including ampicillin (■). From day 10 all rats were dosed with 1000 µg 
ampicillin each day to restore the population of pMR1 containing E. coli cells. The detection limit 
for detection of transformants was 100 cfu/g faeces. Vertical bars represent standard error of the 
mean (SEM). 
 
Figure 2 
In vitro transformation frequencies (transformants per recipient) of B. subtilis 168. An overnight 
culture was diluted in MS media to OD450=0.25. The culture was grown under aerobic conditions at 
37ºC. Every hour, one ml was taken out and different amounts of plasmid (0.1 µg/ml [∆], 1 µg/ml 
[♦], and 10 µg/ml [■] were added. The cultures were incubated for further 1 hr before plating on 
selective media for counting of recipients (LB) and transformants (LB + 5 µg/ml chloramphenicol). 
 
Figure 3 
Faecal concentration (cfu/g faeces) of B. subtilis recipients (■) in eight mono-associated rats. The 
concentration of the dosage culture (cfu/ml) given during the three weeks is also indicated (♦). The 
detection limit for detecting transformants was 10 cfu/g faeces. Vertical bars represent SEM. 
 
Figure 4 
Colonization of eight animals with S. gordonii LTH 5597. Faecal samples were plated on both BHI 
(♦) and BHI including erythromycin (■). From day eight, all rats were dosed with 100 µg 
erythromycin each day to restore the population of pMK110 containing cells. The detection limit 
for detection of transformants was 10 cfu/g faeces. Vertical bars represent SEM. 
 
 
Table 1. Bacterial strains and plasmids 
Strains or plasmids Description Reference or source 
Bacterial strains:   
Escherichia coli   
DB1317  recD1014 (Nuc-) CGSC 
MS15978 DB1317 harbouring pMR1, Apr This study 
MS14395 DH5α, recA1, harbouring pMR2, Cmr [14], this study 
Bacillus subtilis    
Strain 168 1A700 BGSC 
Streptococcus 
gordonii  
  
LTH 5597 TIGR strain harbouring pMK110, Eryr [12] 
 
  
Plasmids:   
pMR1 pBR322 vector, nptII∆NcoI, Apr 
pMR2 pACYC184 vector, nptII without promoter, Cmr 
[10] 
[10] 
pMK110 pMG36e vector, nptII∆NcoI from pMR1, Eryr [15] 
pAW105 pUC19 vector, cat from pC194, Bacillus 
thuringiensis replicon, Apr 
[16] 
   
Plant:   
Solanum tuberosum 
cv. Apriori 
Genetically modified potato containing antisense 
GBSS (granule bound starch synthase) and intact 
nptII 
AVEBE, Foxhole, 
The Netherlands 
Abbreviations: Apr: ampicillin resistance; BGSC: Bacillus Genetic Stock Center; cat: 
chloramphenicol acetyltransferase gene; CGSC: E. coli Genetic Stock Center; Cmr: 
chloramphenicol resistance; Eryr: erythromycin resistance; GBSS: granule bound starch synthase 
gene; nptII: kanamycin resistance gene. 
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